These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 21282357)
21. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line. D'Souza B; Rowe M; Walls D J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681 [TBL] [Abstract][Full Text] [Related]
22. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells. Rechsteiner MP; Berger C; Weber M; Sigrist JA; Nadal D; Bernasconi M J Gen Virol; 2007 May; 88(Pt 5):1454-1459. PubMed ID: 17412973 [TBL] [Abstract][Full Text] [Related]
23. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells. Wasil LR; Wei L; Chang C; Lan L; Shair KH J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552 [TBL] [Abstract][Full Text] [Related]
24. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of HLA-ABC expression through promoter hypermethylation and downmodulation of MIC-A/B surface expression in LMP2A-positive epithelial carcinoma cell lines. Singh S; Banerjee S Sci Rep; 2020 Mar; 10(1):5415. PubMed ID: 32214110 [TBL] [Abstract][Full Text] [Related]
26. Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells. Kuhn-Hallek I; Sage DR; Stein L; Groelle H; Fingeroth JD Blood; 1995 Mar; 85(5):1289-99. PubMed ID: 7858259 [TBL] [Abstract][Full Text] [Related]
27. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Wolf J; Pawlita M; Bullerdiek J; zur Hausen H Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Bornkamm GW Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855 [TBL] [Abstract][Full Text] [Related]
29. l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma. Sang W; Tu D; Zhang M; Qin Y; Yin W; Song X; Sun C; Yan D; Wang X; Zeng L; Li Z; Xu K; Xu L J Biochem Mol Toxicol; 2022 Aug; 36(8):e23117. PubMed ID: 35757978 [TBL] [Abstract][Full Text] [Related]
30. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells. Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723 [TBL] [Abstract][Full Text] [Related]
31. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014 [TBL] [Abstract][Full Text] [Related]
32. Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2. AlQarni S; Al-Sheikh Y; Campbell D; Drotar M; Hannigan A; Boyle S; Herzyk P; Kossenkov A; Armfield K; Jamieson L; Bailo M; Lieberman PM; Tsimbouri P; Wilson JB Oncogene; 2018 Jul; 37(29):3998-4012. PubMed ID: 29691476 [TBL] [Abstract][Full Text] [Related]
33. Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt's lymphoma. Mawson AR; Majumdar S Int J Cancer; 2017 Nov; 141(9):1849-1855. PubMed ID: 28707393 [TBL] [Abstract][Full Text] [Related]
34. Biology of the lymphomas: cytogenetics, molecular biology, and virology. Ambinder RF; Griffin CA Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167 [TBL] [Abstract][Full Text] [Related]
35. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Rowe M; Kelly GL; Bell AI; Rickinson AB Semin Cancer Biol; 2009 Dec; 19(6):377-88. PubMed ID: 19619657 [TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma. Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907 [TBL] [Abstract][Full Text] [Related]
38. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells. Zebboudj A; Maroui MA; Dutrieux J; Touil-Boukoffa C; Bourouba M; Chelbi-Alix MK; Nisole S Biochimie; 2014 Dec; 107 Pt B():247-56. PubMed ID: 25241256 [TBL] [Abstract][Full Text] [Related]
39. The interaction between Vav1 and EBNA1 promotes survival of Burkitt's lymphoma cells by down-regulating the expression of Bim. Wang R; Wang J; Zhang N; Wan Y; Liu Y; Zhang L; Pan S; Zhang C; Zhang H; Cao Y Biochem Biophys Res Commun; 2019 Apr; 511(4):787-793. PubMed ID: 30833082 [TBL] [Abstract][Full Text] [Related]
40. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease. Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]